Replies to post #65828 on Biotech Values

[genisi]

This is very good because the 100 mg/day dose could be co formulated with Truvada.

[DewDiligence]

>IDIX (Reason for yesterday's advance??)<

That the 100mg dose of IDX899 works as monotherapy is excellent news for two reasons:

1. The lower the dose, the better the tolerability will be when IDX899 is added to a standard treatment backbone such as Truvada.

2. The reason mentioned by Genisi (#msg-31929218): a lower dose has a smaller footprint, which facilitates co-formulation into a single pill with Truvada.

--
Still, I don’t think today’s news re the 100mg dose is what drove the share price yesterday because the data reported today were fully expected, IMO.

[DewDiligence]

IDX899 for HIV: 7-day Monotherapy Data